S

Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281

Watchlist Manager
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Watchlist
Price: 31.78 CNY 2.12% Market Closed
Market Cap: 2.3B CNY

Net Margin

12%
Current
Declining
by 2.4%
vs 3-y average of 14.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12%
=
Net Income
¥52.2m
/
Revenue
¥435.5m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12%
=
Net Income
¥52.2m
/
Revenue
¥435.5m

Peer Comparison

Country Company Market Cap Net
Margin
CN
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
2.3B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
276.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
215.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
221.7B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
No Stocks Found

Market Distribution

Higher than 77% of companies in China
Percentile
77th
Based on 8 721 companies
77th percentile
12%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Shandong Keyuan Pharmaceutical Co Ltd
Glance View

Market Cap
2.3B CNY
Industry
Pharmaceuticals

Shandong Keyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical raw materials, and chemical preparation. The company is headquartered in Jinan, Shandong. The company went IPO on 2023-04-04. The firm's main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and others. The firm's products are used in hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The firm conducts its operations mainly in the domestic market.

Shandong Keyuan Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
12%
=
Net Income
¥52.2m
/
Revenue
¥435.5m
What is Shandong Keyuan Pharmaceutical Co Ltd's current Net Margin?

The current Net Margin for Shandong Keyuan Pharmaceutical Co Ltd is 12%, which is below its 3-year median of 14.4%.

How has Net Margin changed over time?

Over the last 2 years, Shandong Keyuan Pharmaceutical Co Ltd’s Net Margin has decreased from 20% to 12%. During this period, it reached a low of 11.5% on Sep 30, 2024 and a high of 20% on Aug 30, 2023.

Back to Top